News
GSK’s Nucala receives US FDA approval for use in adults with chronic obstructive pulmonary disease
GSK’s Nucala receives US FDA approval for use in adults with chronic obstructive pulmonary disease: London, UK Saturday, May 24, 2025, 11:00 Hrs [IST] GSK plc announced that the ...
Pharmacy institutions to be held liable for errors in documents submitted for scholarship: PCI: Gireesh Babu, New Delhi ...
Roche and Broad Clinical Labs collaborate to accelerate adoption of cutting-edge SBX sequencing technology: Basel Saturday, May 24, 2025, 10:00 Hrs [IST] Roche announced a strateg ...
Researchers in UK and India collaborate to tackle antibiotic over-prescription by dentists: Peethaambaran Kunnathoor, Chennai Saturday, May 24, 2025, 09:00 Hrs [IST] Antibiotics p ...
Indian pharma navigates compliance challenges to maintain global credibility by managing cost efficiency: Nandita Vijayasimha, Bengaluru Saturday, May 24, 2025, 08:00 Hrs [IST] In ...
Indian pharma works to prioritize employee centricity with tech-driven HR practices: Nandita Vijayasimha, Bengaluru Saturday, May 24, 2025, 08:00 Hrs [IST] Indian pharma continues ...
India extends deadline for beta naphthol anti-dumping probe questionnaire amid stakeholder requests: Shardul Nautiyal, Mumbai Saturday, May 24, 2025, 08:00 Hrs [IST] The Directora ...
The Union Ministry of Ayush has made amendments to its earlier notification to add a representative from Maharashtra to the Advisory Council for Indian Systems of Medicine, constituted in September, ...
Pfizer and GITAM University empower rural women with employment through Pfizer autonomous teams programme: Our Bureau, Bengaluru Friday, May 23, 2025, 13:30 Hrs [IST] Pfizer Globa ...
Senti Bio gets additional $1.0 million tranche from CIRM grant for advancing clinical development of SENTI-202: South San Francisco, California Friday, May 23, 2025, 16:00 Hrs [IS ...
Sensodyne’s latest campaign highlights Sensitivity as a chronic oral health condition and educates consumers: Our Bureau, Mumbai Friday, May 23, 2025, 17:30 Hrs [IST] Sensodyne, ...
US FDA grants breakthrough therapy designation to Belite Bio’s Tinlarebant for treatment of Stargardt disease: San Diego Friday, May 23, 2025, 17:00 Hrs [IST] Belite Bio, Inc., ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results